BioSig Technologies, Inc. announced that it has entered into a securities purchase agreement for the private placement of 1,550,540 common shares at a price of $1.10928 on March 14, 2023. The transaction will include participation from certain institutional and accredited investors. The company also issued 775,270 warrants at an exercise price of $1.04678 per share.

The warrants will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,719,983.01. The company will issue securities pursuant to Section 4(a)(2) of the Securities Act of 1933 and/or Rule 506 of Regulation D.